These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29171183)

  • 1. Cause-specific mortality in HPV+ and HPV- oropharyngeal cancer patients: insights from a population-based cohort.
    Nørregaard C; Grønhøj C; Jensen D; Friborg J; Andersen E; von Buchwald C
    Cancer Med; 2018 Jan; 7(1):87-94. PubMed ID: 29171183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients.
    Zamani M; Grønhøj C; Jensen DH; Carlander AF; Agander T; Kiss K; Olsen C; Baandrup L; Nielsen FC; Andersen E; Friborg J; von Buchwald C
    Eur J Cancer; 2020 Jul; 134():52-59. PubMed ID: 32460181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
    Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
    Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
    Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.
    Hama T; Tokumaru Y; Fujii M; Yane K; Okami K; Kato K; Masuda M; Mineta H; Nakashima T; Sugasawa M; Sakihama N; Yoshizaki T; Hanazawa T; Kato H; Hirano S; Imanishi Y; Kuratomi Y; Otsuki N; Ota I; Sugimoto T; Suzuki S
    Oncology; 2014; 87(3):173-82. PubMed ID: 25033838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
    Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
    ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
    Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
    Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014.
    Carlander AF; Grønhøj Larsen C; Jensen DH; Garnæs E; Kiss K; Andersen L; Olsen CH; Franzmann M; Høgdall E; Kjær SK; Norrild B; Specht L; Andersen E; van Overeem Hansen T; Nielsen FC; von Buchwald C
    Eur J Cancer; 2017 Jan; 70():75-82. PubMed ID: 27888679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival with HPV among African Americans with oropharyngeal cancer.
    Worsham MJ; Stephen JK; Chen KM; Mahan M; Schweitzer V; Havard S; Divine G
    Clin Cancer Res; 2013 May; 19(9):2486-92. PubMed ID: 23532894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause of Death in Patients with Oropharyngeal Carcinoma by Human Papillomavirus Status: Comparative Data Analysis.
    Zhang DD; Lei M; Wang Y; Zeng PJ; Hong YJ; Cai CF
    JMIR Public Health Surveill; 2023 Aug; 9():e47579. PubMed ID: 37642982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.